Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 8/20 | 0.40 |
| ▸ | CA2 | P00918 | 8/20 | 0.40 |
| ▸ | CA9 | Q16790 | 7/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA7 | P43166 | 3/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.40 |
| ▸ | CA3 | P07451 | 2/20 | 0.40 |
| ▸ | CA4 | P22748 | 2/20 | 0.40 |
| ▸ | CA6 | P23280 | 2/20 | 0.40 |
| ▸ | CA5A | P35218 | 2/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL116906 | 1.00 | DNM1 (0.54) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL7920150 | 1.00 | DNM1 (0.54) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL10822148 | 1.00 | DNM1 (0.54) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL116910 | 1.00 | DNM1 (0.54) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL8752601 | 1.00 | DNM1 (0.54) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL3029039 | 1.00 | DNM1 (0.54) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL116257 | 1.00 | DNM1 (0.54) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL379293 | 1.00 | DNM1 (0.54) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL496059 | 1.00 | DNM1 (0.54) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL179764 | 1.00 | DNM1 (0.54) | DNM1CA1CA2CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 411 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705401-A1 | RHEOLOGY MODIFIER FOR SEALANT OR ADHESIVE FORMULATIONS | Elementis Specialties, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-20240376293-A1 | RHEOLOGY MODIFIER FOR SEALANT OR ADHESIVE FORMULATIONS | ELEMENTIS SPECIALTIES, INC. (US) | 2024-11-14 | — | — | US | claimed |
| WO-2024229220-A1 | RHEOLOGY MODIFIER FOR SEALANT OR ADHESIVE FORMULATIONS | ELEMENTIS SPECIALTIES, INC. (US) | 2024-11-07 | — | — | WO | claimed |
| US-10472266-B2 | Multiple uses of amine salts for industrial water treatment | AMSA, INC. (US) | 2019-11-12 | — | — | US | claimed |
| US-20180155226-A1 | Multiple Uses of Amine Salts for Industrial Water Treatment | AMSA, INC. (US) | 2018-06-07 | — | — | US | claimed |
| US-9919941-B2 | Multiple uses of amine salts for industrial water treatment | AMSA, INC. (US) | 2018-03-20 | — | — | US | claimed |
| EP-2729419-B1 | MULTIPLE USES OF AMINE SALTS FOR INDUSTRIAL WATER TREATMENT | AMSA INC (US) | 2017-06-14 | — | — | EP | claimed |
| US-20160376440-A1 | ASPHALT ADDITIVE, ASPHALT COMPOSITIONS AND PRODUCTS COMPRISING SUCH ADDITIVE, ASPHALT SURFACES COMPRISING SUCH ADDITIVE, METHODS OF MAKING AND USING SUCH ADDITIVE, COMPOSITIONS, SURFACES AND PRODUCTS | GREEN PAVING SOLUTIONS, LLC (US) | 2016-12-29 | — | — | US | claimed |
| US-9006126-B2 | Additive impregnated composition useful in the catalytic hydroprocessing of hydrocarbons, a method of making such catalyst, and a process of using such catalyst | SHELL OIL COMPANY (US) | 2015-04-14 | — | — | US | claimed |
| EP-2798048-A2 | CORROSION INHIBITOR COMPOSITIONS FOR OXYGENATED GASOLINES | Butamax Advanced Biofuels LLC (US) | 2014-11-05 | — | — | EP | claimed |
| US-20070261337-A1 | Novel mineral filler composition | LHOIST NORTH AMERICA, INC. | 2007-11-15 | — | — | US | claimed |
| EP-1471131-A1 | Friction modifier alkoxyamine salts of carboxylic acids as additives for fuel compositions and methods of use thereof | ETHYL CORPORATION (US) | 2004-10-27 | — | — | EP | claimed |
| EP-1462506-A1 | Additives for fuel compositions to reduce formation of combustion chamber deposits | ETHYL CORPORATION (US) | 2004-09-29 | — | — | EP | claimed |
| US-20040010967-A1 | Friction modifier alkoxyamine salts of carboxylic acids as additives for fuel compositions and methods of use thereof | AFTON CHEMICAL INTANGIBLES LLC | 2004-01-22 | — | — | US | claimed |
| US-20040010966-A1 | Additives for fuel compositions to reduce formation of combustion chamber deposits | AFTON CHEMICAL INTANGIBLES LLC | 2004-01-22 | — | — | US | claimed |
| US-6169064-B1 | A LIQUID CONCENTRATE REACTION PRODUCT OF AT LEAST ONE ACID AND AT LEAST ONE AMINE; USEFUL IN MANY DIFFERENT APPLICATIONS ROOF COATINGS, LAUNDRY DETERGENTS, INKS, PAINTS, HARD SURFACE CLEANERS AND SPRAY WAX COMPOSITIONS | TOMAH PRODUCTS, INC. | 2001-01-02 | — | — | US | claimed |
| US-6165952-A | Ashless rust inhibitor lubricant compositions | KING INDUSTRIES, INC. (US) | 2000-12-26 | — | — | US | claimed |
| WO-1999003813-A1 | AMINE ETHER ACID SALT SURFACTANT COMPOSITION | TOMAH PRODUCTS, INC. (US) | 1999-01-28 | — | — | WO | claimed |
| US-5730791-A | ROOF COATING INCLUDING CLAY | TOMAH PRODUCTS, INC. (US) | 1998-03-24 | — | — | US | claimed |
| US-5618340-A | ROOFING | TOMAH PRODUCTS, INC. (US) | 1997-04-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10472266-B2 | Multiple uses of amine salts for industrial water treatment | SLC6A12, SLC6A6, TST | DNM1 2300/4885CA1 1226/4885CA2 597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.